Home > News > 2006 Core Advisory Council Meeting

RCAI News

News
April 17 -18, 2006
2006 Core Advisory Council Meeting


Figure (from left): Drs. Antonio Coutinho, Masaru Taniguchi, Max D. Cooper, William Paul, Ralph Steinman, Bernard Malissen, Klaus Rajewsky, Tasuku Honjo, Paul Kincade, and Nobuyuki Miyasaka.

The Second Core Meeting of the RCAI Advisory Council took place April 17 -18, 2006 at the RCAI research facility on the RIKEN Yokohama campus. The RCAI review and evaluation policy calls for "core" meetings of the Center's scientific advisory board, the Allergy and Immunology Advisory Council (AIAC), every 2-3 years. The agenda of Core AIAC meetings is to review the findings of previous Advisory Council meetings that evaluate research activities annually, and to take a broader look at the Center's research activities, research strategy, future plans, and operating policies. The meeting was attended by Drs. Max D. Cooper (U Alabama Birmingham , USA, Chairman), Antonio Coutinho (Instituto Gulbenkian de Ciencia, Portugal), Tasuku Honjo (Kyoto U, Japan), Paul Kincade (OMRF, USA), Bernard Malissen (Centre d' Immunologie Marseille-Luminy, France), Nobuyuki Miyasaka (Tokyo U, Japan), William Paul (NIH, USA), Klaus Rajewsky (MIT, USA), and Ralph Steinman (Rockefeller U, USA).

Following greetings and introductions by Drs. Taniguchi (RCAI Director), Ogawa (RIKEN Yokohama Institute Director), and Cooper (AC chairman), there was a selection of "highlight" presentations of the most recent research at RCAI. This initial session was followed by an in-depth discussion of the findings of annual individual scientific reviews held throughout the year from June 2005 to April 2006. The findings of these review meetings were evaluated together with the response from each group, team, and unit leader. In a final session, Dr. Taniguchi summarized the present status of the institute and presented the institute's plans for the next five years. Following extensive internal deliberations, Dr. Taniguchi answered questions from the Advisory Council in a final round of discussion. A summary of the findings of the meeting was presented by Dr. Cooper, the Advisory Council's chairman, to Dr. Omori, Deputy Director of the RIKEN Yokohama Institute.

In general, the Advisory Council was extremely pleased with the recent development of the RIKEN Research Center for Allergy and Immunology. They noted that, considering the fact that RCAI moved into the new facilities at the RIKEN Yokohama Institute barely two years ago, he achievements at the center are impressive and research undertaken at the center is outstanding. RCAI's central facilities provide rapid services of high quality that empower smaller research groups by accelerating their internationally competitive research projects. The RCAI International Collaboration Award Program has enhanced international awareness of the Center.

We are grateful to the members of Advisory Council for their intensive discussions, recommendations and encouragement, and RCAI will continue to develop with their endorsement.